Who owns Theravance Biopharma, Inc. (TBPH)? Elite investor 13F holders
4 tracked elite investors reported holding Theravance Biopharma, Inc as of 2026-06-30, including Irenic Capital, D.E. Shaw, Oasis Management, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Irenic Capital | THERAVANCE BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 46936116.00 USD | 2760948.000000 | Shares | hold | Original filing |
| D.E. Shaw | THERAVANCE BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 20151630.00 USD | 1185390.000000 | Shares | add | Original filing |
| Oasis Management | THERAVANCE BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 9919330.00 USD | 583490.000000 | Shares | hold | Original filing |
| Renaissance Technologies LLC | THERAVANCE BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 2623406.00 USD | 154318.000000 | Shares | add | Original filing |
| Tudor Investment | THERAVANCE BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Gotham Asset Management | THERAVANCE BIOPHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.